[{"_id":"556499bdfac443afdd39375f","決算期":"2015年3月期","証券コード":"4967","会社名":"小林製薬(株)【4967】","会計方式":"日本方式","決算発表日":"2015年4月30日","決算月数":"12か月","売上高":"128,344百万円","営業利益":"17,917百万円","経常利益":"18,843百万円","当期利益":"12,448百万円","EPS（一株当たり利益）":"305.46円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,423.54円","総資産":"186,331百万円","自己資本":"139,398百万円","資本金":"3,450百万円","有利子負債":"40百万円","自己資本比率":"74.8%","ROA（総資産利益率）":"6.97%","ROE（自己資本利益率）":"9.35%","総資産経常利益率":"10.55%","日付":"2015-05-26T16:05:17.369Z"},{"_id":"556499bdfac443afdd393760","決算期":"2014年3月期","証券コード":"4967","会社名":"小林製薬(株)【4967】","会計方式":"日本方式","決算発表日":"2014年4月30日","決算月数":"12か月","売上高":"127,293百万円","営業利益":"18,122百万円","経常利益":"18,769百万円","当期利益":"12,307百万円","EPS（一株当たり利益）":"300.55円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,098.32円","総資産":"170,919百万円","自己資本":"126,870百万円","資本金":"3,450百万円","有利子負債":"6百万円","自己資本比率":"74.2%","ROA（総資産利益率）":"7.50%","ROE（自己資本利益率）":"10.18%","総資産経常利益率":"11.44%","日付":"2015-05-26T16:05:17.370Z"},{"_id":"556499bdfac443afdd393761","決算期":"2013年3月期","証券コード":"4967","会社名":"小林製薬(株)【4967】","会計方式":"日本方式","決算発表日":"2013年5月1日","決算月数":"12か月","売上高":"121,532百万円","営業利益":"16,903百万円","経常利益":"18,677百万円","当期利益":"12,176百万円","EPS（一株当たり利益）":"297.37円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,805.27円","総資産":"157,106百万円","自己資本":"114,872百万円","資本金":"3,450百万円","有利子負債":"4百万円","自己資本比率":"73.1%","ROA（総資産利益率）":"7.98%","ROE（自己資本利益率）":"11.24%","総資産経常利益率":"12.25%","日付":"2015-05-26T16:05:17.370Z"}]